JanOne to Present at the Dawson James 8th Annual Investment Conference
Chief Medical Officer Dr. Amol Soin will explain innovative approaches to pain management and JanOne’s development of non-addicting treatments for pain
Related news for (JAN)
- Janux Therapeutics Promotes Zachariah McIver, D.O., Ph.D. to Chief Medical Officer
- Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $402.5 Million
- Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
- Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data in Phase 1a Dose Escalation for JANX007 in mCRPC and Doses Selected for Phase 1b Expansion Studies
- JanOne Subsidiary Increases YoY Transaction Volume by 91%